Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arie van Tol

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|April 19, 2008
Acute elevation of plasma PLTP activity strongly increases pre-existing atherosclerosisMatthijs Moerland, Hannelore Samyn, Teus van Gent, et al.
Journal of Lipid Research|August 20, 2008
Plasma phospholipid transfer activity is essential for increased atherogenesis in PLTP transgenic mice: a mutation-inactivation studyHannelore Samyn, Matthijs Moerland, Teus van Gent, et al.
Transgenic Research|April 18, 2007
Inducible expression of phospholipid transfer protein (PLTP) in transgenic mice: acute effects of PLTP on lipoprotein metabolismMatthijs Moerland, Nora Anghelescu, Hannelore Samyn, et al.
The Journal of Biological Chemistry|October 10, 2002
Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer proteinRien van Haperen, Arie van Tol, Teus van Gent, et al.
Journal of Lipid Research|September 1, 2007
Atherogenic, enlarged, and dysfunctional HDL in human PLTP/apoA-I double transgenic miceMatthijs Moerland, Hannelore Samyn, Teus van Gent, et al.
Diabetes Care|March 29, 2003
Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetesFrancine V van Venrooij, Ronald P Stolk, Jan-Dirk Banga, et al.
Biochimica Et Biophysica Acta|November 22, 2005
Fenofibrate reverses the decline in HDL cholesterol in mice overexpressing human phospholipid transfer proteinJessica Lie, Inge M Lankhuizen, Barbara Gross, et al.
Biochimica Et Biophysica Acta|November 6, 2007
Alterations in lipoprotein homeostasis during human experimental endotoxemia and clinical sepsisJohannes H M Levels, Dasja Pajkrt, Marcus Schultz, et al.
Current Medical Research and Opinion|August 25, 2010
Effect of increasing doses of Rosuvastatin and Atorvastatin on apolipoproteins, enzymes and lipid transfer proteins involved in lipoprotein metabolism and inflammatory parametersIoannis K Karalis, Sandrin C Bergheanu, Ron Wolterbeek, et al.
The Journal of Clinical Endocrinology and Metabolism|January 22, 2011
Plasma cholesteryl ester transfer, but not cholesterol esterification, is related to lipoprotein-associated phospholipase A2: possible contribution to an atherogenic lipoprotein profileRobin P F Dullaart, Alexander Constantinides, Frank G Perton, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Arteriosclerosis, Thrombosis, and Vascular Biology|April 19, 2008
Acute elevation of plasma PLTP activity strongly increases pre-existing atherosclerosisMatthijs Moerland, Hannelore Samyn, Teus van Gent, et al.
Journal of Lipid Research|August 20, 2008
Plasma phospholipid transfer activity is essential for increased atherogenesis in PLTP transgenic mice: a mutation-inactivation studyHannelore Samyn, Matthijs Moerland, Teus van Gent, et al.
Transgenic Research|April 18, 2007
Inducible expression of phospholipid transfer protein (PLTP) in transgenic mice: acute effects of PLTP on lipoprotein metabolismMatthijs Moerland, Nora Anghelescu, Hannelore Samyn, et al.
The Journal of Biological Chemistry|October 10, 2002
Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer proteinRien van Haperen, Arie van Tol, Teus van Gent, et al.
Journal of Lipid Research|September 1, 2007
Atherogenic, enlarged, and dysfunctional HDL in human PLTP/apoA-I double transgenic miceMatthijs Moerland, Hannelore Samyn, Teus van Gent, et al.
Diabetes Care|March 29, 2003
Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetesFrancine V van Venrooij, Ronald P Stolk, Jan-Dirk Banga, et al.
Biochimica Et Biophysica Acta|November 22, 2005
Fenofibrate reverses the decline in HDL cholesterol in mice overexpressing human phospholipid transfer proteinJessica Lie, Inge M Lankhuizen, Barbara Gross, et al.
Biochimica Et Biophysica Acta|November 6, 2007
Alterations in lipoprotein homeostasis during human experimental endotoxemia and clinical sepsisJohannes H M Levels, Dasja Pajkrt, Marcus Schultz, et al.
Current Medical Research and Opinion|August 25, 2010
Effect of increasing doses of Rosuvastatin and Atorvastatin on apolipoproteins, enzymes and lipid transfer proteins involved in lipoprotein metabolism and inflammatory parametersIoannis K Karalis, Sandrin C Bergheanu, Ron Wolterbeek, et al.
The Journal of Clinical Endocrinology and Metabolism|January 22, 2011
Plasma cholesteryl ester transfer, but not cholesterol esterification, is related to lipoprotein-associated phospholipase A2: possible contribution to an atherogenic lipoprotein profileRobin P F Dullaart, Alexander Constantinides, Frank G Perton, et al.
Pageof 6